MariMed Inc. (MRMD.CN)
CAD 0.15
(-11.76%)
CAD 0.15
(-11.76%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 126.2 Million USD | 33.0% |
| 2022 | 94.89 Million USD | 9.19% |
| 2021 | 86.9 Million USD | 27.16% |
| 2020 | 68.34 Million USD | 23.72% |
| 2019 | 55.24 Million USD | 160.63% |
| 2018 | 21.19 Million USD | 0.01% |
| 2017 | 21.19 Million USD | 132.54% |
| 2016 | 9.11 Million USD | 61.33% |
| 2015 | 5.64 Million USD | 57.48% |
| 2014 | 3.58 Million USD | 240.85% |
| 2013 | 1.05 Million USD | 65.59% |
| 2012 | 635.59 Thousand USD | 82.26% |
| 2011 | 348.72 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 132.51 Million USD | 4.99% |
| 2024 Q2 | 139.93 Million USD | -8.74% |
| 2023 Q4 | 126.2 Million USD | 13.75% |
| 2023 FY | 126.2 Million USD | 33.0% |
| 2023 Q1 | 119.12 Million USD | 25.53% |
| 2023 Q2 | 108.46 Million USD | -8.95% |
| 2023 Q3 | 110.95 Million USD | 2.3% |
| 2022 FY | 94.89 Million USD | 9.19% |
| 2022 Q1 | 93.39 Million USD | 7.47% |
| 2022 Q2 | 88.42 Million USD | -5.32% |
| 2022 Q4 | 94.89 Million USD | 2.23% |
| 2022 Q3 | 92.82 Million USD | 4.97% |
| 2021 Q2 | 78.1 Million USD | 3.75% |
| 2021 FY | 86.9 Million USD | 27.16% |
| 2021 Q1 | 75.28 Million USD | 10.15% |
| 2021 Q3 | 82.93 Million USD | 6.18% |
| 2021 Q4 | 86.9 Million USD | 4.79% |
| 2020 FY | 68.34 Million USD | 23.72% |
| 2020 Q4 | 68.34 Million USD | -5.56% |
| 2020 Q2 | 72.26 Million USD | -1.88% |
| 2020 Q3 | 72.36 Million USD | 0.15% |
| 2020 Q1 | 73.64 Million USD | 33.31% |
| 2019 Q4 | 55.24 Million USD | 1.81% |
| 2019 Q2 | 50.85 Million USD | 58.4% |
| 2019 Q1 | 32.1 Million USD | 51.45% |
| 2019 Q3 | 54.26 Million USD | 6.71% |
| 2019 FY | 55.24 Million USD | 160.63% |
| 2018 Q4 | 21.19 Million USD | 2.74% |
| 2018 FY | 21.19 Million USD | 0.01% |
| 2018 Q2 | 23.79 Million USD | 2.56% |
| 2018 Q1 | 23.2 Million USD | 9.48% |
| 2018 Q3 | 20.63 Million USD | -13.31% |
| 2017 FY | 21.19 Million USD | 132.54% |
| 2017 Q1 | 9.95 Million USD | 9.27% |
| 2017 Q2 | 10.08 Million USD | 1.24% |
| 2017 Q3 | 13.28 Million USD | 31.78% |
| 2017 Q4 | 21.19 Million USD | 59.51% |
| 2016 Q1 | 6.83 Million USD | 21.05% |
| 2016 Q3 | 9.25 Million USD | 25.82% |
| 2016 Q4 | 9.11 Million USD | -1.5% |
| 2016 FY | 9.11 Million USD | 61.33% |
| 2016 Q2 | 7.35 Million USD | 7.55% |
| 2015 Q3 | 5.96 Million USD | 3.75% |
| 2015 Q1 | 4.38 Million USD | 22.31% |
| 2015 Q4 | 5.64 Million USD | -5.3% |
| 2015 Q2 | 5.75 Million USD | 31.05% |
| 2015 FY | 5.64 Million USD | 57.48% |
| 2014 Q2 | 1.56 Million USD | 38.9% |
| 2014 Q4 | 3.58 Million USD | 2.8% |
| 2014 FY | 3.58 Million USD | 240.85% |
| 2014 Q3 | 3.48 Million USD | 122.32% |
| 2014 Q1 | 1.13 Million USD | 7.37% |
| 2013 Q2 | 847.45 Thousand USD | 12.14% |
| 2013 Q4 | 1.05 Million USD | 12.64% |
| 2013 Q1 | 755.71 Thousand USD | 18.9% |
| 2013 Q3 | 934.4 Thousand USD | 10.26% |
| 2013 FY | 1.05 Million USD | 65.59% |
| 2012 Q4 | 635.59 Thousand USD | 32.44% |
| 2012 Q2 | 404.22 Thousand USD | 3.75% |
| 2012 Q1 | 389.62 Thousand USD | 0.0% |
| 2012 FY | 635.59 Thousand USD | 82.26% |
| 2012 Q3 | 479.92 Thousand USD | 18.73% |
| 2011 Q2 | 319.22 Thousand USD | 0.0% |
| 2011 FY | 348.72 Thousand USD | 0.0% |
| 2011 Q3 | 354.15 Thousand USD | 10.94% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -4197.943% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | -781.409% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -26711.734% |
| The BC Bud Corporation | 626 Thousand CAD | -20061.053% |
| BioNxt Solutions Inc. | 6.55 Million CAD | -1826.791% |
| CordovaCann Corp. | 11.29 Million CAD | -1017.791% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | -1384.636% |
| Captor Capital Corp. | 28.76 Million CAD | -338.766% |
| City View Green Holdings Inc. | 3.73 Million CAD | -3280.925% |
| 1CM Inc. | 9.42 Million CAD | -1239.275% |
| Global Hemp Group Inc. | 5.82 Million CAD | -2066.625% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -496.054% |
| IM Cannabis Corp. | 35.11 Million CAD | -259.437% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -5031.244% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | -1151.956% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -48818.217% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -2766.202% |
| Ovation Science Inc. | 728.99 Thousand CAD | -17212.81% |
| Pharmadrug Inc. | 2.92 Million CAD | -4214.144% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -5941.729% |
| RAMM Pharma Corp. | 2.83 Million CAD | -4351.014% |
| RIV Capital Inc. | 275.63 Million CAD | 54.212% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -3607.739% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 65.388% |
| SLANG Worldwide Inc. | 37.58 Million CAD | -235.817% |
| 1933 Industries Inc. | 23.28 Million CAD | -442.068% |
| Red Light Holland Corp. | 3.82 Million CAD | -3202.467% |
| Top Strike Resources Corp. | 20.99 Million CAD | -501.167% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -15876.733% |
| Adastra Holdings Ltd. | 17.65 Million CAD | -614.756% |